| Outcome | Group I (RTS) (n = 171) | Group II (LTS) (n = 171) | X² | P | ||
| No | % | No | % | |||
| Overall rate of complications | 66 | 38.5 | 85 | 49.7 | 4.28 | 0.03* |
| Rebleeding | 30 | 17.5 | 46 | 26.9 | 4.33 | 0.03* |
| Infection | 18 | 10.5 | 37 | 21.6 | 7.82 | 0.005* |
| Cardiac complications | 0 | 0.0 | 3 | 1.8 | 3.02 | 0.08 |
| Stroke and TIA | 2 | 1.2 | 3 | 1.8 | 0.203 | 0.65 |
| Acute kidney injury | 12 | 7.0 | 12 | 7.0 | 0.00 | 1.00 |
| Allergic reactions | 14 | 8.2 | 19 | 11.1 | 0.83 | 0.36 |
| Death rate | 13 | 7.6 | 25 | 14.6 | 4.26 | 0.03* |